AAPL327.44-6.30 (-1.89%) ▼|ABBV254.00-0.49 (-0.19%) ▼|ABT101.20+0.52 (+0.51%) ▲|ACN141.65-1.92 (-1.34%) ▼|ADBE228.72-8.53 (-3.60%) ▼|AMAT538.27+8.61 (+1.63%) ▲|AMD511.80+16.04 (+3.23%) ▲|AMGN366.92+0.63 (+0.17%) ▲|AMT168.89-1.17 (-0.69%) ▼|AMZN249.62+2.39 (+0.97%) ▲|AVGO378.57+7.75 (+2.09%) ▲|AXP353.16-2.20 (-0.62%) ▼|BA209.73-4.30 (-2.01%) ▼|BAC60.71-0.56 (-0.91%) ▼|BKNG179.14-2.54 (-1.40%) ▼|BLK1,057.21-14.99 (-1.40%) ▼|BMY61.25+0.51 (+0.84%) ▲|BNY157.78+0.65 (+0.41%) ▲|BRK-B490.83-0.08 (-0.02%) ▼|C129.51+0.15 (+0.12%) ▲|CAT879.13+0.48 (+0.05%) ▲|CL91.73-0.72 (-0.78%) ▼|CMCSA23.64-0.16 (-0.65%) ▼|COF207.61-0.42 (-0.20%) ▼|COP115.18+0.47 (+0.41%) ▲|COST944.73+3.86 (+0.41%) ▲|CRM168.87-1.90 (-1.11%) ▼|CSCO112.52+0.58 (+0.52%) ▲|CVS108.01+0.54 (+0.50%) ▲|CVX188.51+1.13 (+0.60%) ▲|DE591.17-6.07 (-1.02%) ▼|DHR203.49-0.34 (-0.17%) ▼|DIS96.40-1.27 (-1.30%) ▼|DUK126.68+1.67 (+1.34%) ▲|EMR137.09-2.45 (-1.76%) ▼|FDX308.61-4.38 (-1.40%) ▼|GD371.98+3.40 (+0.92%) ▲|GE347.96-0.87 (-0.25%) ▼|GEV1,081.24+23.40 (+2.21%) ▲|GILD133.87-0.41 (-0.31%) ▼|GM76.01-0.06 (-0.08%) ▼|GOOG358.50+12.38 (+3.58%) ▲|GOOGL358.73+11.96 (+3.45%) ▲|GS1,060.00-5.22 (-0.49%) ▼|HD335.22-3.65 (-1.08%) ▼|HON225.17+0.15 (+0.07%) ▲|IBM210.51-2.17 (-1.02%) ▼|INTC97.78+2.74 (+2.88%) ▲|INTU282.98-8.12 (-2.79%) ▼|ISRG346.67+1.25 (+0.36%) ▲|JNJ251.70-1.34 (-0.53%) ▼|JPM341.29+0.19 (+0.06%) ▲|KO82.17+0.61 (+0.75%) ▲|LIN515.25+2.03 (+0.40%) ▲|LLY1,169.32-9.79 (-0.83%) ▼|LMT511.67+2.90 (+0.57%) ▲|LOW204.39-4.35 (-2.08%) ▼|LRCX312.98-0.33 (-0.10%) ▼|MA542.86-0.75 (-0.14%) ▼|MCD268.87+1.16 (+0.43%) ▲|MDLZ60.29-0.71 (-1.16%) ▼|MDT83.32+0.12 (+0.14%) ▲|META643.84-2.17 (-0.34%) ▼|MMM161.29+1.45 (+0.91%) ▲|MO74.58+0.37 (+0.50%) ▲|MRK126.61-0.89 (-0.70%) ▼|MS213.84-1.67 (-0.77%) ▼|MSFT394.25+0.43 (+0.11%) ▲|MU872.51+23.56 (+2.77%) ▲|NEE89.30+0.50 (+0.56%) ▲|NFLX67.54-1.41 (-2.05%) ▼|NKE43.12-0.64 (-1.46%) ▼|NOW99.07-4.17 (-4.04%) ▼|NVDA205.22+2.41 (+1.19%) ▲|ORCL120.58-5.83 (-4.61%) ▼|PEP136.64-0.49 (-0.35%) ▼|PFE24.94-0.12 (-0.46%) ▼|PG149.62-0.36 (-0.24%) ▼|PLTR132.80+0.42 (+0.32%) ▲|PM193.05+0.07 (+0.04%) ▲|QCOM171.76-0.02 (-0.01%) ▼|RTX196.71+3.20 (+1.65%) ▲|SBUX106.09+0.60 (+0.57%) ▲|SCHW100.49-1.07 (-1.05%) ▼|SO95.43+0.13 (+0.14%) ▲|SPG230.04+1.34 (+0.59%) ▲|T21.83+0.02 (+0.09%) ▲|TMO529.02-3.47 (-0.65%) ▼|TMUS193.04+0.61 (+0.32%) ▲|TSLA374.72-6.13 (-1.61%) ▼|TXN289.55+5.53 (+1.95%) ▲|UBER72.23-0.23 (-0.32%) ▼|UNH422.09-4.00 (-0.94%) ▼|UNP300.40-1.35 (-0.45%) ▼|UPS113.72-4.00 (-3.40%) ▼|USB63.27+0.13 (+0.21%) ▲|V359.07+0.51 (+0.14%) ▲|VZ43.48-0.12 (-0.26%) ▼|WFC86.96-0.55 (-0.63%) ▼|WMT113.99-0.25 (-0.22%) ▼|XOM148.37+1.01 (+0.68%) ▲|AAPL327.44-6.30 (-1.89%) ▼|ABBV254.00-0.49 (-0.19%) ▼|ABT101.20+0.52 (+0.51%) ▲|ACN141.65-1.92 (-1.34%) ▼|ADBE228.72-8.53 (-3.60%) ▼|AMAT538.27+8.61 (+1.63%) ▲|AMD511.80+16.04 (+3.23%) ▲|AMGN366.92+0.63 (+0.17%) ▲|AMT168.89-1.17 (-0.69%) ▼|AMZN249.62+2.39 (+0.97%) ▲|AVGO378.57+7.75 (+2.09%) ▲|AXP353.16-2.20 (-0.62%) ▼|BA209.73-4.30 (-2.01%) ▼|BAC60.71-0.56 (-0.91%) ▼|BKNG179.14-2.54 (-1.40%) ▼|BLK1,057.21-14.99 (-1.40%) ▼|BMY61.25+0.51 (+0.84%) ▲|BNY157.78+0.65 (+0.41%) ▲|BRK-B490.83-0.08 (-0.02%) ▼|C129.51+0.15 (+0.12%) ▲|CAT879.13+0.48 (+0.05%) ▲|CL91.73-0.72 (-0.78%) ▼|CMCSA23.64-0.16 (-0.65%) ▼|COF207.61-0.42 (-0.20%) ▼|COP115.18+0.47 (+0.41%) ▲|COST944.73+3.86 (+0.41%) ▲|CRM168.87-1.90 (-1.11%) ▼|CSCO112.52+0.58 (+0.52%) ▲|CVS108.01+0.54 (+0.50%) ▲|CVX188.51+1.13 (+0.60%) ▲|DE591.17-6.07 (-1.02%) ▼|DHR203.49-0.34 (-0.17%) ▼|DIS96.40-1.27 (-1.30%) ▼|DUK126.68+1.67 (+1.34%) ▲|EMR137.09-2.45 (-1.76%) ▼|FDX308.61-4.38 (-1.40%) ▼|GD371.98+3.40 (+0.92%) ▲|GE347.96-0.87 (-0.25%) ▼|GEV1,081.24+23.40 (+2.21%) ▲|GILD133.87-0.41 (-0.31%) ▼|GM76.01-0.06 (-0.08%) ▼|GOOG358.50+12.38 (+3.58%) ▲|GOOGL358.73+11.96 (+3.45%) ▲|GS1,060.00-5.22 (-0.49%) ▼|HD335.22-3.65 (-1.08%) ▼|HON225.17+0.15 (+0.07%) ▲|IBM210.51-2.17 (-1.02%) ▼|INTC97.78+2.74 (+2.88%) ▲|INTU282.98-8.12 (-2.79%) ▼|ISRG346.67+1.25 (+0.36%) ▲|JNJ251.70-1.34 (-0.53%) ▼|JPM341.29+0.19 (+0.06%) ▲|KO82.17+0.61 (+0.75%) ▲|LIN515.25+2.03 (+0.40%) ▲|LLY1,169.32-9.79 (-0.83%) ▼|LMT511.67+2.90 (+0.57%) ▲|LOW204.39-4.35 (-2.08%) ▼|LRCX312.98-0.33 (-0.10%) ▼|MA542.86-0.75 (-0.14%) ▼|MCD268.87+1.16 (+0.43%) ▲|MDLZ60.29-0.71 (-1.16%) ▼|MDT83.32+0.12 (+0.14%) ▲|META643.84-2.17 (-0.34%) ▼|MMM161.29+1.45 (+0.91%) ▲|MO74.58+0.37 (+0.50%) ▲|MRK126.61-0.89 (-0.70%) ▼|MS213.84-1.67 (-0.77%) ▼|MSFT394.25+0.43 (+0.11%) ▲|MU872.51+23.56 (+2.77%) ▲|NEE89.30+0.50 (+0.56%) ▲|NFLX67.54-1.41 (-2.05%) ▼|NKE43.12-0.64 (-1.46%) ▼|NOW99.07-4.17 (-4.04%) ▼|NVDA205.22+2.41 (+1.19%) ▲|ORCL120.58-5.83 (-4.61%) ▼|PEP136.64-0.49 (-0.35%) ▼|PFE24.94-0.12 (-0.46%) ▼|PG149.62-0.36 (-0.24%) ▼|PLTR132.80+0.42 (+0.32%) ▲|PM193.05+0.07 (+0.04%) ▲|QCOM171.76-0.02 (-0.01%) ▼|RTX196.71+3.20 (+1.65%) ▲|SBUX106.09+0.60 (+0.57%) ▲|SCHW100.49-1.07 (-1.05%) ▼|SO95.43+0.13 (+0.14%) ▲|SPG230.04+1.34 (+0.59%) ▲|T21.83+0.02 (+0.09%) ▲|TMO529.02-3.47 (-0.65%) ▼|TMUS193.04+0.61 (+0.32%) ▲|TSLA374.72-6.13 (-1.61%) ▼|TXN289.55+5.53 (+1.95%) ▲|UBER72.23-0.23 (-0.32%) ▼|UNH422.09-4.00 (-0.94%) ▼|UNP300.40-1.35 (-0.45%) ▼|UPS113.72-4.00 (-3.40%) ▼|USB63.27+0.13 (+0.21%) ▲|V359.07+0.51 (+0.14%) ▲|VZ43.48-0.12 (-0.26%) ▼|WFC86.96-0.55 (-0.63%) ▼|WMT113.99-0.25 (-0.22%) ▼|XOM148.37+1.01 (+0.68%) ▲|
24.9 C
New York
Monday, July 20, 2026

Tag: ASA

HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Readout from Legacy Ultimovacs DOVACC Phase II Trial Concludes UV1 Programme as Previously Guided

Oslo, 26 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that the NSGO-CTU sponsored Phase II DOVACC clinical trial (NCT04742075) investigating the Ultimovacs UV1 cancer vaccine, inherited through the business combination between the two companies in 2025, did not meet the primary endpoint. This concludes the previously communicated wrap-up phase of the UV1 cancer vaccine programme and Zelluna now considers the programme closed.

Resultater fra Ultimovacs’ DOVACC fase II-studie bekrefter avslutningen av UV1-programmet, i tråd med tidligere kommunisert plan

Oslo, 26. juni 2026 – Zelluna (OSE: ZLNA), et selskap som utvikler allogene "off-the-shelf" T-cellereseptor-baserte NK-celler (TCR-NK) for behandling av solide kreftformer, kunngjør i dag at den NSGO-CTU sponsede fase II DOVACC kliniske studie (NCT04742075) som testet Ultimovacs' UV1 kreftvaksine ikke oppnådde sitt primære endepunkt om å forbedre progresjonsfri overlevelse (PFS). UV1 ble overtatt gjennom virksomhetssammenslåingen mellom de to selskapene i 2025. Dette avslutter den tidligere kommuniserte avviklingsfasen av UV1-kreftvaksine-programmet, og Zelluna anser nå programmet som avsluttet.

DNO Annual General Meeting Held; All Resolutions Passed by Shareholders

Oslo, 26 June 2026 – DNO ASA, the Norwegian oil and gas operator, today held its 2026 Annual General Meeting. All resolutions passed with strong shareholder support. Minutes of the meeting, held virtually, are attached.

New name registered – Voim ASA

Reference is made to the stock exchange notice published by Voim ASA (the "Company") on 24 June 2026 regarding the completion of the annual general meeting of the Company and that all items on the agenda had been resolved in accordance with the respective proposals.

Orrön Energy announces strategic transaction to create a leading Nordic IPP

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Cloudberry Clean Energy ASA (“Cloudberry”) to combine the Company’s Nordic renewable energy platform and organisation, excluding the Karskruv windfarm, with Cloudberry (the “Transaction”), creating a leading Nordic independent power producer (“IPP”). As consideration for the Transaction, Orrön Energy will receive 27.01 percent of the shares in the enlarged Cloudberry, becoming its largest shareholder. In addition, loan balances and accrued interest of approximately MEUR 93 as of year-end 2025 will be settled or assumed by Cloudberry, and Orrön Energy will receive MEUR 4.2 in cash. Orrön Energy will take an active role in Cloudberry’s future growth through Board representation, bringing Orrön Energy’s and the Lundin Group’s experience of value creation into the combined entity. Orrön Energy will continue to own the Karskruv windfarm and its large-scale European development business, consisting of data centres, solar and battery projects.

Orrön Energy offentliggör strategisk transaktion för att skapa en ledande nordisk oberoende elproducent

Orrön Energy AB (”Orrön Energy” eller ”Bolaget”) meddelar att Bolaget har ingått ett avtal med Cloudberry Clean Energy ASA (”Cloudberry”) om att kombinera Bolagets nordiska plattform och organisation inom förnybar energi, exklusive vindkraftsparken Karskruv, med Cloudberry (”Transaktionen”), och därigenom skapa en ledande nordisk oberoende elproducent (”IPP”). Som ersättning för Transaktionen kommer Orrön Energy att erhålla 27,01 procent av aktierna i ett större Cloudberry, och därmed bli dess största aktieägare. Dessutom kommer utestående lån inklusive upplupen ränta som per utgången av 2025 uppgick till cirka 93 MEUR sammanlagt att regleras eller övertas av Cloudberry, och Orrön Energy kommer att erhålla 4,2 MEUR i kontant köpeskilling. Orrön Energy kommer att ta en aktiv roll i Cloudberrys framtida tillväxt genom styrelserepresentation och bidra med erfarenhet av värdeskapande från Lundin-gruppen till den sammanslagna verksamheten. Orrön Energy kommer fortsatt att äga vindkraftsparken Karskruv och den storskaliga projektverksamheten i Europa inom datacenter, solenergi och batterier.

Equinor ASA: Share buy-back – second tranche for 2026

Please see below information about transactions made under the second tranche of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Equinor ASA: Tilbakekjøp av egne aksjer – andre transje for 2026

Nedenfor følger informasjon om transaksjoner foretatt under andre transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2026.

SalMar – Ex. dividend NOK 10 today

The shares in SalMar ASA will be quoted ex-dividend of NOK 10.00 per share as from today, 23 June 2026.

Changes to the Board of Directors

(Oslo, Norway, 22 June 2026) – Hedda Felin has been elected to the Board of Directors of Statkraft, replacing Ingelise Arntsen, who is stepping down from the Board.

Endringer i styret

(Oslo, Norge, 22. juni 2026) – Hedda Felin er valgt inn i styret i Statkraft. Hun erstatter Ingelise Arntsen, som trer ut av styret.

Regulatory announcement no 12: Stabilisation measures taken

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

Carbon Capture & Storage Market Size to Reach USD 6.7 Billion by 2033, at 7.0% CAGR, Driven by Decarbonization Initiatives, Emission Reduction Mandates, and...

Growing deployment across power generation and industrial applications, coupled with supportive government policies and advancements in carbon capture technologies, continues to accelerate market expansion...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsASA